Epileptic seizure semiology in infants and children

Jun T Park1, Guadalupe Fernandez-Baca Vaca1

  • 1Rainbow Babies & Children's Hospital, Cleveland, Ohio, United States; Epilepsy Center, University Hospitals, Cleveland, Ohio, United States; Case Western Reserve University School of Medicine, Cleveland, Ohio, United States.

Seizure
|November 12, 2019
PubMed

Insights

Seizure semiology in children provides crucial clues for identifying the epileptogenic zone. However, interpreting these signs can be complex due to developmental changes and potential localization ambiguity in young patients.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Epileptology

Background:

  • Epileptic seizure semiology is vital for hypothesizing the epileptogenic zone.
  • Seizure manifestations in infants and children evolve with brain maturation.
  • Focal lesions can present with generalized signs, and focal signs may mislead localization in pediatric epilepsy.

Purpose of the Study:

  • To review seizure semiology in children aged one month to ten years.
  • To correlate seizure semiology with the lateralization and localization of the epileptogenic zone.

Main Methods:

  • Review of seizure semiology in pediatric patients (1 month to 10 years).
  • Analysis of semiological features in relation to epileptogenic zone lateralization and localization.

Main Results:

  • Seizure semiology in children is initially simple and becomes more complex with age.
  • Generalized seizure semiology can occur with focal lesions.
  • Focal seizure signs may present misleading localization information.

Conclusions:

  • Understanding developmental changes in seizure semiology is key in pediatric epilepsy.
  • Careful semiological analysis is necessary for accurate epileptogenic zone localization in children.
  • Seizure semiology, despite complexities, remains a critical tool for localizing epilepsy foci in pediatric patients.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.5K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
763